Olga Zaslaver

663 total citations
7 papers, 145 citations indexed

About

Olga Zaslaver is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Olga Zaslaver has authored 7 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Infectious Diseases. Recurrent topics in Olga Zaslaver's work include Epigenetics and DNA Methylation (2 papers), Adenosine and Purinergic Signaling (1 paper) and Viral Infections and Immunology Research (1 paper). Olga Zaslaver is often cited by papers focused on Epigenetics and DNA Methylation (2 papers), Adenosine and Purinergic Signaling (1 paper) and Viral Infections and Immunology Research (1 paper). Olga Zaslaver collaborates with scholars based in Canada, United States and Hungary. Olga Zaslaver's co-authors include Beth Nicholson, Karen Browning, K. Andrew White, Adam P. Rosebrock, Amy A. Caudy, James E. Cox, Hongde Li, Jason M. Tennessen, Geetanjali Chawla and Jonathan A. Karty and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Virology.

In The Last Decade

Olga Zaslaver

7 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Zaslaver Canada 6 82 37 21 20 18 7 145
Jennifer Becker United States 11 208 2.5× 65 1.8× 10 0.5× 12 0.6× 9 0.5× 22 305
David Dorris United States 9 313 3.8× 54 1.5× 9 0.4× 17 0.8× 10 0.6× 11 368
Zong-Ming Guo China 5 139 1.7× 72 1.9× 7 0.3× 38 1.9× 12 0.7× 7 209
Athina Theodosiou Cyprus 9 189 2.3× 47 1.3× 8 0.4× 6 0.3× 13 0.7× 16 269
Alexander Stuckey United States 5 77 0.9× 31 0.8× 4 0.2× 8 0.4× 6 0.3× 7 150
Kyotaro Hirashima Japan 5 136 1.7× 143 3.9× 3 0.1× 16 0.8× 18 1.0× 5 283
P. Daniela Garcia United States 4 447 5.5× 57 1.5× 12 0.6× 15 0.8× 25 1.4× 4 496
Laure Schaeffer France 9 285 3.5× 26 0.7× 34 1.6× 3 0.1× 12 0.7× 11 385
Mathieu Catala Canada 12 432 5.3× 85 2.3× 4 0.2× 53 2.6× 19 1.1× 14 494

Countries citing papers authored by Olga Zaslaver

Since Specialization
Citations

This map shows the geographic impact of Olga Zaslaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Zaslaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Zaslaver more than expected).

Fields of papers citing papers by Olga Zaslaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Zaslaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Zaslaver. The network helps show where Olga Zaslaver may publish in the future.

Co-authorship network of co-authors of Olga Zaslaver

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Zaslaver. A scholar is included among the top collaborators of Olga Zaslaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Zaslaver. Olga Zaslaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ubhi, Tajinder, Olga Zaslaver, Andrew T. Quaile, et al.. (2024). Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells. Nature Cancer. 5(6). 895–915. 12 indexed citations
2.
Yu, Pei, Hisham M. Ibrahim, Corey A. Scipione, et al.. (2023). Oxidized Low-Density Lipoprotein Accumulation Suppresses Glycolysis and Attenuates the Macrophage Inflammatory Response by Diverting Transcription from the HIF-1α to the Nrf2 Pathway. The Journal of Immunology. 211(10). 1561–1577. 15 indexed citations
3.
Masud, Sanna N., Megha Chandrashekhar, Michael Aregger, et al.. (2022). Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux. Nature Chemical Biology. 18(12). 1370–1379. 7 indexed citations
4.
Puumala, Emily, Olga Zaslaver, Amy Chen, et al.. (2022). The Trisubstituted Isoxazole MMV688766 Exerts Broad-Spectrum Activity against Drug-Resistant Fungal Pathogens through Inhibition of Lipid Homeostasis. mBio. 13(6). e0273022–e0273022. 5 indexed citations
5.
Li, Hongde, Geetanjali Chawla, Olga Zaslaver, et al.. (2017). Drosophila larvae synthesize the putative oncometabolite L-2-hydroxyglutarate during normal developmental growth. Proceedings of the National Academy of Sciences. 114(6). 1353–1358. 57 indexed citations
6.
Xu, Mengshu, Olga Zaslaver, Ashrut Narula, et al.. (2016). Mitochondrial control through nutritionally regulated global histone H3 lysine-4 demethylation. Scientific Reports. 6(1). 37942–37942. 11 indexed citations
7.
Nicholson, Beth, et al.. (2012). Tombusvirus Y-Shaped Translational Enhancer Forms a Complex with eIF4F and Can Be Functionally Replaced by Heterologous Translational Enhancers. Journal of Virology. 87(3). 1872–1883. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026